This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Henry M. Feder, Jr, MD; Diane L. Whitaker, MD; Diane M. Hoss, MD

Arch Dermatol. 1997;133(1):93-94.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

LYME DISEASE in Europe and the United States is caused by different strains of the spirochete Borrelia burgdorferi. Therefore, the clinical manifestations of Lyme disease may be different in these 2 locations.^1-3 For example, in the United States, the pathognomonic rash erythema migrans (EM) will persist for 1 to 4 weeks without treatment, whereas in Europe the rash will persist for 2 to 16 weeks if left untreated. In Europe, the rash is termed erythema chronicum migrans (ECM). Multiple EM and arthritis occur more frequently in the United States than in Europe. Borrelia lymphocytoma, acrodermatitis chronica atrophicans, and focal neuralgias occur commonly in Europe but are unusual in the United States. Because of these differences, conclusions based on European studies cannot be generalized to the United States.

In this issue of the ARCHIVES, Hulshof and colleagues⁴ from the Netherlands report on the excellent outcome of 44 European patients . . . [Full Text PDF of this Article]

Author Affiliations
University of Connecticut Health Center 263 Farmington Ave Farmington, CT 06030

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?